Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
This explainer defines global market indices, explains their purpose, and outlines how they aggregate data from multiple markets.
27,297 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Oil markets roiled by Hormuz disruptions push energy ETFs past the 50% mark for the year, prompting a closer look at ...
July 16 could be a pivotal date for Nvidia and the broader AI chip ecosystem. This guide explains why Nvidia investor...
Aflac has a remarkable 43-year streak of raising its dividend, a hallmark many income investors look for. But that st...
Two tech giants are racing to dominate AI. This guide breaks down why Alphabet and Amazon could be the better artific...
A high-flying AI infrastructure stock surged 176% in a single year. This guide breaks down what powered that move, wh...
Oil prices jump and inflation data loom, setting the stage for a volatile week in crypto markets as traders weigh mac...
This in-depth look breaks down SAIC's saic (saic) 2026 earnings landscape, weighing revenue drivers, margins, and ris...
Dairy Queen's leader says Buffett taught him a simple truth: passion for the mission matters more than being the smar...
TD Cowen boosts its Match Group target on better Tinder metrics, while UBS stays cautious. The market tests whether T...
Tether rolled out a decentralized local AI initiative linked to its stability framework, calling it a new form of int...
A suspected multichain exploit on THORChain prompted rapid emergency halts across several networks, challenging the p...